Selective elevation of circulating CCL2/MCP1 levels in patients with longstanding post-vaccinal macrophagic myofasciitis and ASIA

Current Medicinal Chemistry

Volumn 21, Issue 4, 2014, Pages 511-517

  Cadusseau, Josette ^a,b,c   Ragunathan Thangarajah, Nilusha ^a,b,d   Surenaud, Mathieu ^a   Hue, Sophie ^a   Authier, Francois Jérôme ^a,b,d   Gherardi, Romain K ^a,b,d  

^a INSERM U955   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c FACULTÉ DE MÉDECINE   (France)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

Alum; CCL 2 MCP1; Cytokinome; Inflammatory cytokine; Macrophagic myofasciitis; Vaccine adjuvant

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INTERLEUKIN 1BETA; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TETANUS TOXOID;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE SYNDROME INDUCED BY ADJUVANT; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; FASCIITIS; FEMALE; HUMAN; MACROPHAGIC MYOFASCIITIS; MALE; MUSCLE BIOPSY; RISK ASSESSMENT; VACCINATION REACTION;

ADJUVANTS, IMMUNOLOGIC; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; CHEMOKINE CCL2; COHORT STUDIES; FASCIITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOSITIS; VACCINES;

EID: 84893254377     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113206660287     Document Type: Article

References (75)

1. Moxon, E.R.; Siegrist, C.A. The next decade of vaccines, societal and scientific challenges. Lancet, 2011, 378(9788), 348-59.
2. Agmon-Levin, N.; Paz, Z.; Israeli, E.; Shoenfeld, Y. Vaccines and autoimmunity. Nat Rev Rheumatol. 2009, 5(11), 648-52.
3. Molina, V.; Shoenfeld, Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity. 2005, 38(3), 235-45. (Pubitemid 40959897)
4. Stübgen, JP. Neuromuscular disorders associated with Hepatitis B vaccination. J Neurol Sci. 2010, 292(1-2), 1-4.
5. Gherardi, R.K.; Coquet, M.; Cherin, P.; Belec, L.; Moretto, P.; Dreyfus, P.A.; Pelissier, J.F.; Chariot, P.; Authier, F.J. Macrophagic myofasciitis lesions assess long-term persistence of vaccinederived aluminium hydroxide in muscle. Brain. 2001, 124, 1821-1831 (Pubitemid 32845443)
6. Petrik, M.S.; Wong, M.C.; Tabata, R.C.; Garry, R.F.; Shaw, C.A. Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice. Neuromolecular Med. 2007, 9(1), 83-100. (Pubitemid 44772277)
7. Asa, P.B.; Cao, Y.; Garry, R.F. Antibodies to squalene in Gulf War syndrome. Exp Mol Pathol. 2000, 68(1), 55-64. (Pubitemid 30082846)
8. Nohynek, H.; Jokinen, J.; Partinen, M.; Vaarala, O.; Kirjavainen, T.; Sundman, J.; Himanen, S.L.; Hublin, C.; Julkunen, I.; Olsén, P.; Saarenpää-Heikkilä, O.; Kilpi, T. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One, 2012, 7(3), e33536.
9. Exley, C.; Siesjö, P.; Eriksson, H. The immunobiology of aluminium adjuvants, how do they really work? Trends Immunol. 2010, 31, 103-109.
10. Marrack, P.; McKee, A.S.; Munks, M.W. Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol. 2009, 9, 287-293.
11. Hornung, V.; Bauernfeind, F.; Halle, A.; Samstad, E.O.; Kono, H.; Rock, K.L.; Fitzgerald, K.A.; Latz, E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008, 9, 847-56.
12. Rosenblum, H.; Shoenfeld, Y.; Amital, H. The common immunogenic etiology of chronic fatigue syndrome, from infections to vaccines via adjuvants to the ASIA syndrome. Infect Dis Clin North Am. 2011, 25(4), 851-63.
13. Shoenfeld, Y.; Agmon-Levin, N. "ASIA" - autoimmune / inflammatory syndrome induced by adjuvants. J. Autoimmun. 2011, 36, 4-8.
14. Gherardi, R.K. Lessons from macrophagic myofasciitis, towards definition of a vaccine adjuvant-related syndrome. Rev Neurol (Paris). 2003, 159(2) 162-164. (Pubitemid 36292557)
15. Gherardi, R.K.; Authier, F.J. Aluminum inclusion macrophagic myofasciitis, a recently identified condition. Immunol Allergy Clin North Am. 2003, 23, 699-712. (Pubitemid 38030164)
16. Hotopf, M.; David, A.; Hull, L.; Khalida, I.; Unwin, C.; Wessely, S. Role of vaccinations as risk factors for ill health in veterans of the Gulf war, cross sectional study. BMJ. 2000, 320, 1363-1367. (Pubitemid 30261115)
17. Shaw, C.A.; Petrik, M.S.J. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. J Inorg Biochem 2009, 103, 1555-1562
18. Miyoshi, K.; Miyamura, T.; Kobayashi, Y.; Itakura, T.; Nishijo, K. Hypergammaglobulinemia by prolonged adjuvanticity in man dis orders developed after augmentation mammoplasty. Jpn Med J. 1964, 2122, 9-14
19. Shoaib, B.O.; Patten, B.M. Human adjuvant disease, presentation as a 414 multiple sclerosis-like syndrome. South Med J. 1996, 89, 179-88. (Pubitemid 26055946)
20. Meroni, P.L. Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA), old truths and a new syndrome? J Autoimmun. 2011, 36(1), 1-3.
21. Cervera, R. 'ASIA', a new systemic autoimmune syndrome? Lupus. 2011, 20(7), 665-6.
22. Hughes, G.R.V. Foreword- Special issue of Lupus on ASIA. Lupus. 2012, 21, 117.
23. Vasey, F.B.; Zarabadi, S.A.; Seleznick, M.; Ricca, L. Where there's smoke there's fire, the silicone breast implant controversy continues to flicker, a new disease that needs to be defined. J Rheumatol. 2003, 30(10), 2092-4. (Pubitemid 37221835)
24. Gherardi, R.K.; Coquet, M.; Chérin, P.; Authier, F.J.; Laforêt, P.; Bélec, L.; Figarella-Branger D.; Mussini, J.M.; Pellissier, J.F.; Fardeau, M. Macrophagic myofasciitis, an emerging entity. Lancet. 1998, 352(9125), 347-52.
25. Couette, M.; Boisse, M.F.; Maison, P.; Brugieres, P.; Cesaro, P.; Chevalier, X.; Gherardi, R.K.; Bachoud-Levi, A.C.; Authier, F.J. Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction. J Inorg Biochem. 2009, 103, 1571-1578.
26. Passeri, E.; Villa, C.; Couette, M.; Itti, E.; Brugieres, P.; Cesaro, P.; Gherardi, R.K.; Bachoud-Levi, A.C.; Authier, F.J. Long-term follow- up of cognitive dysfunction in patients with aluminium hydroxide- induced macrophagic myofasciitis (MMF). J Inorg Biochem. 2011, 105, 1457-1463.
27. Authier, F.J.; Sauvat, S.; Champey, J.; Drogou, I.; Coquet, M.; Gherardi, R. Chronic fatigue syndrome in patients with macrophagic myofasciitis. Arthritis Rheum. 2003, 48, 569-570. (Pubitemid 36278027)
28. Authier, F.J.; Cherin, P.; Creange, A.; Bonnotte, B.; Ferrer, X.; Abdelmoumni, A.; Ranoux, D.; Pelletier, J.; Figarella-Branger, D.; Granel, B.; Maisonobe, T.; Coquet, M.; Degos, J-D.; Gherardi, R.K. Central nervous system disease in patients with macrophagic myofasciitis. Brain, 2001, 124(Pt 5), 974-83. (Pubitemid 32458509)
29. Hornung, V.; Bauernfeind, F.; Halle, A.; Samstad, E.O.; Kono, H.; Rock, K.L.; Fitzgerald, K.A.; Latz, E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008, 9, 847-56
30. Seubert, A.; Monaci, E.; Pizza, M.; O'Hagan, D.T.; Wack, A. The adjuvants aluminium hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J Immunol. 2008, 180(8), 5402-12.
31. Nakano, H.; Lin, KL.; Yanagita, M.; Charbonneau, C.; Cook, DN.; Kakiuchi, T.; Gunn, M.D. Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat Immunol. 2009, 10, 394-402
32. Gu, L.; Tseng, S.; Horner, R.M.; Tam, C.; Loda, M.; Rollins, B.J. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature, 2000, 404(6776), 407-11. (Pubitemid 30164344)
33. Deshmane, S.L.; Kremlev, S.; Amini, S.; Sawaya, B.E. Monocyte chemoattractant protein-1 (MCP-1), an overview. J Interferon Cytokine Res. 2009, 29(6), 313-26.
34. Brigitte, M.; Schilte, C.; Plonquet, A.; Baba-Amer, Y.; Henri, A.; Charlier, C.; Tajbakhsh, S.; Albert, M.; Gherardi, R.K.; Chrétien, F. Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury. Arthritis Rheum. 2010, 62(1), 268-79.
35. Izikson, L.; Klein, R.S.; Charo, I.F.; Weiner, H.L.; Luster, A.D. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med. 2000, 192(7), 1075-80.
36. Mildner, A.; Schmidt, H.; Nitsche, M.; Merkler, D.; Hanisch, U.K.; Mack, M.; Heikenwalder, M.; Brück, W.; Priller, J.; Prinz, M. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci. 2007, 10, 1544-53. (Pubitemid 350175884)
37. Authier, F.J.; Sauvat, S.; Christov, C.; Chariot, P.; Raisbeck, G.; Poron, M.F.; Yiou, F.; Gherardi, R. AlOH3-adjuvanted vaccine induced macrophagic myofasciitis in rats is influenced by the genetic background. Neuromuscul Disord. 2006, 16, 347-352.
38. Brenner, D.; Labreuche, J.; Touboul, P.J.; Schmidt-Petersen, K.; Poirier, O.; Perret, C.; Schönfelder, J.; Combadière, C.; Lathrop, M.; Cambien, F.; Brand-Herrmann, S.M.; Amarenco, P., GENIC Investigators. Cytokine polymorphisms associated with carotid intima- media thickness in stroke patients. Stroke. 2006, 37(7), 1691-6. (Pubitemid 44297714)
39. Flores-Villanueva, P.O.; Ruiz-Morales, J.A.; Song, C.H.; Flores, L.M.; Jo, E.K.; Montaño, M.; Barnes, P.F.; Selman, M.; Granados, J. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med. 2005, 19, 202(12), 1649-58. (Pubitemid 41815871)
40. Navratilova, Z.; Mrazek, F.; Kriegova, E.; Hutyrova, B.; Kolek, V.; du Bois, R.M.; Petrek, M.The MCP-1 2518 (A to G) single nucleotide polymorphism in Czech patients with pulmonary sarcoidosis, association with Löfgren's syndrome. Sarcoidosis Vasc. Diffuse Lung Dis. 2007, 24(1), 33-8. (Pubitemid 350177770)
41. Nadif, R.; Mintz, M.; Rivas-Fuentes, S.; Jedlicka, A.; Lavergne, E.; Rodero, M.; Kauffmann F.; Combadière, C.; Kleeberger, S.R. Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis. Cytokine. 2006, 33(3), 171-8.
42. Tucci, M.; Barnes, E.V.; Sobel, E.S.; Croker, B.P.; Segal, M.S.; Reeves, W.H.; Richards, H.B.; Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum. 2004, 50(6), 1842-9. (Pubitemid 38725097)
43. Malafronte, P.; Vieira, J.M. Jr.; Pereira, A.C.; Krieger, J.E.; Barros, R.T.; Woronik, V. Association of the MCP-1 -2518 A/G polymorphism and no association of its receptor CCR2 -64 V/I polymorphism with lupus nephritis. J. Rheumatol. 2010, 37(4), 776-82.
44. Gonzalez, E.; Rovin, B.H.; Sen, L.; Cooke, G.; Dhanda, R.; Mummidi, S.; Kulkarni, H.; Bamshad, M.J.; Telles, V.; Anderson, S.A.; Walter, E.A.; Stephan, K.T.; Deucher, M.; Mangano, A.; Bologna, R.; Ahuja, S.S.; Dolan, M.J.; Ahuja, S.K.; HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A. 2002, 99(21), 13795-800. (Pubitemid 35215460)
45. Khan, Z.; Combadiere, C.; Authier, F.J.; Itier, V.; Lux, F.; Exley, C.; Mahrouf-Yorgov, M.; Decrouy, X.; Moretto, P.; Tillement, O.; Gherardi, R.K.; Cadusseau, J. Slow CCL2-dependent translocation of biopersistent particles from muscle to brain. BMC Med. 2013, doi, 10.1186/1741-7015-11-99
46. Mansfield, A.S.; Nevala, W.K.; Dronca, R.S.; Leontovich, A.A.; Shuster, L.; Markovic, S.N.; Normal ageing is associated with an increase in Th2 cells, MCP-1 (CCL2) and RANTES (CCL5), with differences in sCD40L and PDGF-AA between sexes. Clin Exp Immunol. 2012, 170(2), 186-93.
47. Harris, J.; De Haro, S.A.; Master, S.S.; Keane, J.; Roberts, E.A.; Delgado, M.; Deretic, V. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity. 2007, 27(3), 505-17. (Pubitemid 47418681)
48. Eidi, H.; Joubert, O.; Némos, C.; Grandemange, S.; Mograbi, B.; Foliguet, B.; Tournebize, J.; Maincent, P.; Le Faou, A.; Aboukhamis, I.; Rihn, B.; Drug delivery by polymeric nanoparticles induces autophagy in macrophages Int J Pharm. 2012, 422(1-2), 495-503.
49. Rioux, J.D.; Xavier, R.J.; Taylor, K.D.; Silverberg, M.S.; Goyette, P.; Huett, A.; Green, T.; Kuballa, P.; Barmada, M.M.; Datta, L.W.; Shugart, Y.Y.; Griffiths, A.M.; Targan, S.R.; Ippoliti A. F.; Bernard, E.J.; Mei, L.; Nicolae, D.L.; Regueiro, M.; Schumm, L.P.; Steinhart, A.H.; Rotter, J.I.; Duerr, R.H.; Cho, J.H.; Daly, M.J.; Brant, SR. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007, 39(5), 596-604. (Pubitemid 46676115)
50. Lerner, A. Aluminum as an adjuvant in Crohn's disease induction. Lupus. 2012, 21(2), 231-8.
51. Landay, A.L.; Jessop, C, ; Lennette, E.T.; Levy J.A. Chronic fatigue syndrome, clinical condition associated with immune activation. Lancet. 1991, 338, 707-12.
52. Sukocheva, O.A.; Marmion, B.P.; Storm, P.A.; Lockhart, M.; Turra, M.; Graves, S. Long-term persistence after acute Q fever of non-infective Coxiella burnetii cell components, including antigens. QJM. 2010, 103, 847-63
53. Bélec, L.; Authier, F.J.; Gherardi, RK. Safety and immunogenicity of hepatitis B vaccine regimens in adults with HIV-1. JAMA. 2011, 306, 156
54. Seneff, S.; Davidson, R.L. Jingjing. Empirical data confirm Autism Symptoms related to aluminum and acetaminophen exposure. Entropy. 2012, 14, 2227-2253
55. Tomljenovic, L. Aluminum and Alzheimer's disease, after a century of controversy, is there a plausible link? J of Alzheimers Dis. 2011, 23, 567-598
56. Kool M.; Fierens K.; Lambrecht B.N. Alum adjuvant, some of the tricks of the oldest adjuvant. J Med Microbiol. 2012, 61, 927-34
57. Lee S.H. Detection of human papillomavirus (HPV) L1 gene DNA possibly bound to particulate aluminum adjuvant in the HPV vaccine Gardasil. J Inorg Biochem. 2012, 117, 85-92.
58. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci U S A. 1996, 93, 2879-83 (Pubitemid 26116242)
59. Stienstra R.; van Diepen J.A.; Tack C.J.; Zaki M.H.; van de Veerdonk F.L.; Perera D.; Neale G.A.; Hooiveld G.J.; Hijmans A.; Vroegrijk I.; van den Berg S.; Romijn J.; Rensen P.C.; Joosten L.A.; Netea M.G.; Kanneganti T.D. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A. 2011; 108, 15324-9.
60. Vilaysane A.; Chun J.; Seamone M.E.; Wang W.; Chin R.; Hirota S.; Li Y.; Clark SA.; Tschopp J.; Trpkov K.; Hemmelgarn B.R.; Beck P.L.; Muruve D.A. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol. 2010, 21, 1732-44.
61. Mélik-Parsadaniantz, S.; Rostène, W.; Chemokines and neuromodulation. J Neuroimmunol. 2008, 198(1-2), 62-8.
62. Mahad, D.J.; Ransohoff, R.M.; The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin Immunol. 2003, 15, 23-32. (Pubitemid 36092176)
63. Sokolova, A.; Hill, M.D.; Rahimi, F.; Warden, L.A.; Halliday, G.M.; Shepherd, C.E.; Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease. Brain Pathol.,. 2009, 19(3), 392-8.
64. Dhillon, N.K.; Williams, R.; Callen, S.; Zien, C.; Narayan, O.; Buch, S. Roles of MCP-1 in development of HIV-dementia. Front Biosci. 2008, 13, 3913-8. (Pubitemid 351594669)
65. Godefroy, D.; Gosselin, R.D.; Yasutake, A.; Fujimura, M.; Combadière, C.; Maury-Brachet R.; Laclau, M.; Rakwal, R.; Melik-Parsadaniantz, S.; Bourdineaud, J.P.; Rostène, W. The chemokine CCL2 protects against methylmercury neurotoxicity. Toxicol Sci. 2012, 125(1), 209-18.
66. Huang, D.; Wujek, J.; Kidd, G.; He, T.T.; Cardona, A.; Sasse, M.E.; Stein, E.J.; Kish, J.; Tani, M.; Charo, I.F.; Proudfoot, A.E.; Rollins, B.J.; Handel, T.; Ransohoff, R.M. Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice. FASEB J. 2005, 19(7), 761-72. (Pubitemid 40617380)
67. Menetski, J.; Mistry, S.; Lu, M.; Mudgett, J.S.; Ransohoff, R.M.; Demartino, J.A.; Macintyre D.E.; Abbadie, C. Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses. Neuroscience. 2007, 149, 706-714. (Pubitemid 47633032)
68. Jung, H.; Toth, P.T.; White, F.A.; Miller, R.J. Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons. J Neurochem. 2008, 104, 254-263. (Pubitemid 350265055)
69. Thacker, M.A.; Clark, A.K.; Bishop, T.; Grist, J.; Yip, P.K.; Moon, L.D.; Thompson, S.W.; Marchand, F.; McMahon, S.B.; CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain. 2009, 13, 263-272.
70. Gao, Y.J.; Ji, R.R. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther. 2010, 126, 56-68.
71. Ang, D.C.; Moore, M.N.; Hilligoss, J.; Tabbey, R. MCP1 and IL8 as pain biomarkers in fibromyalgia, a Pilot Study Pain Med. 2011, 12, 1154-61.
72. Galimberti, D.; Fenoglio, C.; Lovati, C.; Venturelli, E.; Guidi, I.; Corrà, B.; Scalabrini, D.; Clerici, F.; Mariani, C.; Bresolin, N.; Scarpini, E. Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease. Neurobiol Aging. 2006, 27(12), 1763-8. (Pubitemid 44572579)
73. Chazaud, B.; Sonnet, C.; Lafuste, P.; Bassez, G.; Rimaniol, AC.; Poron, F.; Authier, F.J.; Dreyfus, P.A.; Gherardi, R.K.; Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol. 2003, 16, 1133-43. (Pubitemid 37541888)
74. Hubal, M.J.; Chen, T.C.; Thompson, P.D.; Clarkson, P.M. Inflammatory gene changes associated with the repeated-bout effect. Am J Physiol Regul Integr Comp Physiol. 2008, 294, R1628-R1637
75. Gherardi R.K.; Authier F.J. Macrophagic myofasciitis, characterization and pathophysiology. Lupus. 2012, 21, 184-9.